Skip to main navigation Skip to search Skip to main content

VERGLEICH DER KLINISCHEN WIRKSAMKEIT VON 40 MG UND 60 MG RETARDIERTEM ISOSORBID-5-MONONITRAT BEI PATIENTEN MIT KORONARER HERZKRANKHEIT

Translated title of the contribution: Comparison of therapeutic efficacy of 40 mg and 60 mg sustained release isosorbide-5-nitrate in patients with coronary artery disease

E. Schmidt, E. Schmidt

Translated title of the contributionComparison of therapeutic efficacy of 40 mg and 60 mg sustained release isosorbide-5-nitrate in patients with coronary artery disease
Original languageGerman
JournalHerz Kreislauf
Volume19
Issue number9
Pages (from-to)444-449
Number of pages6
ISSN0046-7324
Publication statusPublished - 1987

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this